The alliance is aimed at advancing the research of solutions for dermatological diseases Almirall’s chief executive officer, Carlos Gallardo, and Alberto Granados, country general manager of Microsoft Spain Almirall has announced a strategic partnership with Microsoft to accelerate digitalisation and technology innovation within medical dermatology. The three-year collaboration, which will combine Almirall’s research and development knowledge in drug discovery with Microsoft’s digital technologies, is aimed at advancing the research of medical solutions for dermatological diseases, developing next-generation personalised drugs, and accelerating Almirall’s overall digital transformation. Though financial details of the deal have not been disclosed, Almirall outlined that it will work with Microsoft Industry Solutions, in collaboration with some Microsoft partners, to establish a joint ‘Digital Office’ to build on its own unified data platform, and drive digital innovation in drug discovery and development by employing generative artificial intelligence (AI) and advanced analytics technologies. Almirall’s chief executive officer, Carlos Gallardo, said: “This agreement with Microsoft is a significant advancement in our digital transformation to achieve our goal of delivering novel treatment options for patients. It will empower us to apply [the] latest technologies to transform our ways of working and accelerate drug discovery.” Throughout the collaboration, Almirall added that […]
K&X Design and Investment Technology, LLC
Invest The Invisible Impact
K&X Design and Investment Technology, LLC
Invest The Invisible Impact
